Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses

Authors: Ines Schneider, Mandy D Lehmann, Vlada Kogosov, Eggert Stockfleth, Ingo Nindl

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Cutaneous human papillomavirus (HPV) infections seem to be associated with the onset of actinic keratosis (AK). This study compares the presence of cutaneous HPV types in eyebrow hairs to those in tissues of normal skin and skin lesions of 75 immunocompetent AK patients.

Methods

Biopsies from AK lesions, normal skin and plucked eyebrow hairs were collected from each patient. DNA from these specimens was tested for the presence of 28 cutaneous HPV (betaPV and gammaPV) by a PCR based method.

Results

The highest number of HPV prevalence was detected in 84% of the eyebrow hairs (63/75, median 6 types) compared to 47% of AK lesions (35/75, median 3 types) (p< 0.001) and 37% of normal skin (28/75, median 4 types) (p< 0.001), respectively. A total of 228 HPV infections were found in eyebrow hairs compared to only 92 HPV infections in AK and 69 in normal skin. In all three specimens HPV20, HPV23 and/or HPV37 were the most prevalent types. The highest number of multiple types of HPV positive specimens was found in 76% of the eyebrow hairs compared to 60% in AK and 57% in normal skin. The concordance of at least one HPV type in virus positive specimens was 81% (three specimens) and 88-93% of all three combinations with two specimens.

Conclusions

Thus, eyebrow hairs revealed the highest number of cutaneous HPV infections, are easy to collect and are an appropriate screening tool in order to identify a possible association of HPV and AK.
Appendix
Available only for authorised users
Literature
1.
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology. 2004, 324: 17-27. 10.1016/j.virol.2004.03.033.CrossRefPubMed
2.
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010, 401: 70-79. 10.1016/j.virol.2010.02.002.CrossRefPubMedPubMedCentral
3.
International Agency for Research on Cancer: IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. IARC Lyon France. 1995, 64:
4.
zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002, 2: 342-350. 10.1038/nrc798.CrossRefPubMed
5.
Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, Schegget JT, Bouwes Bavinck JN: A case–control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant. 2011, 11: 1498-1508. 10.1111/j.1600-6143.2011.03589.x.CrossRefPubMed
6.
Struijk L, Bouwes Bavinck JN, Wanningen P, van der Meijden E, Westendorp RG, Ter Schegget J, Feltkamp MC: Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol. 2003, 121: 1531-1535. 10.1046/j.1523-1747.2003.12632.x.CrossRefPubMed
7.
Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC: Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res. 2010, 70: 9777-9786. 10.1158/0008-5472.CAN-10-0352.CrossRefPubMed
8.
Muschik D, Braspenning-Wesch I, Stockfleth E, Rosl F, Hofmann TG, Nindl I: Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One. 2011, 6: e27655-10.1371/journal.pone.0027655.CrossRefPubMedPubMedCentral
9.
Akgül B, Garcia-Escudero R, Ghali L, Pfister HJ, Fuchs PG, Navsaria H, Storey A: The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 2005, 65: 2216-2223. 10.1158/0008-5472.CAN-04-1952.CrossRefPubMed
10.
Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M, de Villiers EM, Filotico R, Boukamp P, Tommasino M: The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol. 2003, 77: 2195-2206. 10.1128/JVI.77.3.2195-2206.2003.CrossRefPubMedPubMedCentral
11.
Iftner T, Elbel M, Schopp B, Hiller T, Loizou JI, Caldecott KW, Stubenrauch F: Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J. 2002, 21: 4741-4748. 10.1093/emboj/cdf443.CrossRefPubMedPubMedCentral
12.
Jackson S, Storey A: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene. 2000, 19: 592-598. 10.1038/sj.onc.1203339.CrossRefPubMed
13.
Nafz J, Kohler A, Ohnesorge M, Nindl I, Stockfleth E, Rosl F: Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol. 2007, 88: 2670-2678. 10.1099/vir.0.82955-0.CrossRefPubMed
14.
Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, Fuchs P, Pfister H: Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 2005, 65: 1394-1400. 10.1158/0008-5472.CAN-04-3263.CrossRefPubMed
15.
Viarisio D, Mueller-Decker K, Kloz U, Aengeneyndt B, Kopp-Schneider A, Grone HJ, Gheit T, Flechtenmacher C, Gissmann L, Tommasino M: E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog. 2011, 7: e1002125-10.1371/journal.ppat.1002125.CrossRefPubMedPubMedCentral
16.
Jablonska S, Dabrowski J, Jakubowicz K: Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 1972, 32: 583-589.PubMed
17.
Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M, Rzesa G: Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A. 1978, 75: 1537-1541. 10.1073/pnas.75.3.1537.CrossRefPubMedPubMedCentral
18.
Majewski S, Jablonska S: Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol. 1997, 36: 659-685. 10.1016/S0190-9622(97)80315-5.CrossRefPubMed
19.
Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M: The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev. 2009, 73: 348-370. 10.1128/MMBR.00033-08.CrossRefPubMedPubMedCentral
20.
Borgogna C, Zavattaro E, De AM, Griffin HM, Dell’oste V, Azzimonti B, Landini MM, Peh WL, Pfister H, Doorbar J, Landolfo S, Gariglio M: Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology. 2012, 423: 195-204. 10.1016/j.virol.2011.11.029.CrossRefPubMed
21.
Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E: Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev. 2001, 25: 533-547.PubMed
22.
de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, Green AC, Harwood CA, Naldi L, Neale R, Nindl I, Proby CM, Quint WG, Sampogna F, ter Schegget J, Struijk L, Wieland U, Pfister HJ, Feltkamp MC: Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol. 2009, 90: 1611-1621. 10.1099/vir.0.010017-0.CrossRefPubMed
23.
Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U: Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol. 2005, 125: 93-97. 10.1111/j.0022-202X.2005.23733.x.CrossRefPubMed
24.
Pfister H: Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr. 2003, 52-56.
25.
Akgül B, Cooke JC, Storey A: HPV-associated skin disease. J Pathol. 2006, 208: 165-175. 10.1002/path.1893.CrossRefPubMed
26.
Nindl I, Gottschling M, Stockfleth E: Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations. Dis Markers. 2007, 23: 247-259.CrossRefPubMedPubMedCentral
27.
Boxman IL, Berkhout RJM, Mulder LHC, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget JT: Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol. 1997, 108: 712-715. 10.1111/1523-1747.ep12292090.CrossRefPubMed
28.
de Koning MN, Struijk L, Bavinck JN, Kleter B, ter Schegget J, Quint WG, Feltkamp MC: Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol. 2007, 88: 1489-1495. 10.1099/vir.0.82732-0.CrossRefPubMed
29.
Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG: A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol. 1999, 80: 2437-2443.CrossRefPubMed
30.
Kohler A, Forschner T, Meyer T, Ulrich C, Gottschling M, Stockfleth E, Nindl I: Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol. 2007, 156: 1078-1080. 10.1111/j.1365-2133.2007.07809.x.CrossRefPubMed
31.
Nindl I, Gottschling M, Krawtchenko N, Lehmann MD, Rowert-Huber J, Eberle J, Stockfleth E, Forschner T: Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis. Br J Dermatol. 2007, 156 (Suppl 3): 34-39.CrossRefPubMed
32.
Brink AA, Lloveras B, Nindl I, Heideman DA, Kramer D, Pol R, Fuente MJ, Meijer CJ, Snijders PJ: Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol. 2005, 43: 5581-5587. 10.1128/JCM.43.11.5581-5587.2005.CrossRefPubMedPubMedCentral
33.
Nindl I, Kohler A, Gottschling M, Forschner T, Lehmann M, Meijer CJ, Snijders PJ, Stockfleth E: Extension of the typing in a general-primer-PCR reverse-line-blotting system to detect all 25 cutaneous beta human papillomaviruses. J Virol Methods. 2007, 146: 1-4. 10.1016/j.jviromet.2007.05.022.CrossRefPubMed
34.
Nindl I, Meyer T, Schmook T, Ulrich C, Ridder R, Audring H, Sterry W, Stockfleth E: Human papillomavirus and overexpression of P16INK4a in nonmelanoma skin cancer. Dermatol Surg. 2004, 30: 409-414. 10.1111/j.1524-4725.2004.30111.x.PubMed
35.
Nindl I, Kohler A, Meyer T, Forschner T, Meijer CJ, Snijders PJ, Sterry W, Stockfleth E: Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases. Br J Dermatol. 2006, 154: 797-799. 10.1111/j.1365-2133.2006.07173.x.CrossRefPubMed
36.
Weissenborn S, et al: Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol. 2012, 201: 117-125. 10.1007/s00430-011-0212-3.CrossRefPubMed
37.
Struijk L, Hall L, van der Meijden E, Wanningen P, Bavinck JN, Neale R, Green AC, ter Schegget J, Feltkamp MC: Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15: 529-535. 10.1158/1055-9965.EPI-05-0747.CrossRefPubMed
38.
Plasmeijer EI, Neale RE, de Koning MN, Quint WG, McBride P, Feltkamp MC, Green AC: Persistence of betapapillomavirus infections as a risk factor for actinic keratoses, precursor to cutaneous squamous cell carcinoma. Cancer Res. 2009, 69: 8926-8931. 10.1158/0008-5472.CAN-09-1186.CrossRefPubMed
39.
Escutia B, Ledesma E, Serra-Guillen C, Gimeno C, Vilata JJ, Guillen C, Nagore E: Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects. J Eur Acad Dermatol Venereol. 2011, 25: 832-838. 10.1111/j.1468-3083.2010.03875.x.CrossRefPubMed
40.
Plasmeijer EI, Neale RE, Buettner PG, de Koning MN, ter Schegget J, Quint WG, Green AC, Feltkamp MC: Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer. 2010, 126: 2614-2621.PubMed
41.
Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M: High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res. 2003, 295: 273-279. 10.1007/s00403-003-0435-2.CrossRefPubMed
Metadata
Title
Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses
Authors
Ines Schneider
Mandy D Lehmann
Vlada Kogosov
Eggert Stockfleth
Ingo Nindl
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-186

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue

Case report

Poststreptococcal syndrome mimicking conjunctival lymphoma

Research article

Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial

Research article

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

Research article

Detection of dengue viruses using reverse transcription-loop-mediated isothermal amplification

Research article

Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy

Research article

Genotypic and phenotypic analysis of diarrheagenic Escherichia coli strains isolated from Brazilian children living in low socioeconomic level communities
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits